Molecular mechanisms of carbapenem resistance in enterobacter cloacae clinical isolates from Korea and clinical outcome

Annals of Clinical and Laboratory Science

Volumn 42, Issue 3, 2012, Pages 281-286

  Lee, Yangsoon ^a,b   Choi, Heekyeong ^c   Yum, Jong Hwa ^d   Kang, Girung ^a   Bae, Il Kwon ^a   Jeong, Seok Hoon ^a   Lee, Kyungwon ^a  

^a Yonsei University College of Medicine   (South Korea)

^b National Health Insurance Corporation   (South Korea)

^c Wonju Severance Christian Hospital   (South Korea)

^d Dong Eui University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CARBAPENEM; CEFOTAXIME; CEFPIRAMIDE; CEFTIZOXIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; DNA 16S; ERTAPENEM; IMIPENEM; ISEPAMICIN; LEVOFLOXACIN; LINEZOLID; MEROPENEM; OUTER MEMBRANE PROTEIN F; PIPERACILLIN PLUS TAZOBACTAM; SULPERAZON; TEICOPLANIN; VANCOMYCIN;

ABDOMINAL INFECTION; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CHILD; CLINICAL ARTICLE; DNA HYBRIDIZATION; ENTEROBACTER CLOACAE; FEMALE; HUMAN; INFANT; KOREA; MALE; MOLECULAR MECHANICS; MOUTH INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PNEUMONIA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT FAILURE; TREATMENT OUTCOME;

AGED; BACTERIAL OUTER MEMBRANE PROTEINS; BETA-LACTAMASES; CARBAPENEMS; CHILD; DRUG RESISTANCE, MICROBIAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENTEROBACTER CLOACAE; FEMALE; GENES, BACTERIAL; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; REPUBLIC OF KOREA; TREATMENT OUTCOME;

ENTEROBACTER CLOACAE;

EID: 84868664237     PISSN: 00917370     EISSN: 15508080     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bratu, S., D. Landman, R. Haag, R. Recco, A. Eramo, M. Alam, and J. Quale. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch Intern Med 2005; 165:1430-5.
2. Marchaim, D., S. Navon-Venezia, M. J. Schwaber, and Y. Carmeli. Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes. Antimicrob Agents Chemother 2008; 52:1413-8.
3. Patel, G., S. Huprikar, S. H. Factor, S. G. Jenkins, and D. P. Calfee. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008; 29:1099-106.
4. Falcone, M., M. L. Mezzatesta, M. Perilli, C. Forcella, A. Giordano, V. Cafiso, G. Amicosante, S. Stefani, and M. Venditti. Infections with VIM-1 metallo-{beta}-lactamaseproducing enterobacter cloacae and their correlation with clinical outcome. J Clin Microbiol 2009; 47:3514-9.
5. Nordmann, P., S. Mariotte, T. Naas, R. Labia, and M. H. Nicolas. Biochemical properties of a carbapenem-hydrolyzing beta-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli. Antimicrob Agents Chemother 1993; 37:939-46.
6. Rasmussen, B. A., K. Bush, D. Keeney, Y. Yang, R. Hare, C. O'Gara, and A. A. Medeiros. Characterization of IMI-1 betalactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae. Antimicrob Agents Chemother 1996; 40:2080-6.
7. Chen, L. R., H. W. Zhou, J. C. Cai, R. Zhang, and G. X. Chen. Detection of plasmid-mediated IMP-1 metallo-betalactamase and quinolone resistance determinants in an ertapenem-resistant Enterobacter cloacae isolate. J Zhejiang Univ Sci B 2009; 10:348-54.
8. Ikonomidis, A., N. Spanakis, A. Poulou, S. Pournaras, F. Markou, and A. Tsakris. Emergence of carbapenem-resistant Enterobacter cloacae carrying VIM-4 metallo-beta-lactamase and SHV-2a extended-spectrum beta-lactamase in a conjugative plasmid. Microb Drug Resist 2007; 13:221-6.
9. Trevino, M., L. Moldes, L. Martinez-Lamas, C. Varon, and B. J. Regueiro. Carbapenem-resistant Enterobacter cloacae and the emergence of metallo-beta-lactamase-producing strains in a third-level hospital (Santiago de Compostela, NW Spain). Eur J Clin Microbiol Infect Dis 2009; 28:1253-8.
10. Jeong, S. H., K. Lee, Y. Chong, J. H. Yum, S. H. Lee, H. J. Choi, J. M. Kim, K. H. Park, B. H. Han, S. W. Lee, and T. S. Jeong. Characterization of a new integron containing VIM-2, a metallo- beta-lactamase gene cassette, in a clinical isolate of Enterobacter cloacae. J Antimicrob Chemother 2003; 51:397-400.
11. Pages, J. M., C. E. James, and M. Winterhalter. The porin and the permeating antibiotic: a selective diffusion barrier in Gramnegative bacteria. Nat Rev Microbiol 2008; 6:893-903.
12. Szabo, D., F. Silveira, A. M. Hujer, R. A. Bonomo, K. M. Hujer, J. W. Marsh, C. R. Bethel, Y. Doi, K. Deeley, and D. L. Paterson. Outer membrane protein changes and efflux pump expression together may confer resistance to ertapenem in Enterobacter cloacae. Antimicrob Agents Chemother 2006; 50:2833-5.
13. Bennett, J. W., K. Mende, M. L. Herrera, X. Yu, J. S. Lewis, 2nd, B. L. Wickes, J. H. Jorgensen, and C. K. Murray. Mechanisms of carbapenem resistance among a collection of Enterobacteriaceae clinical isolates in a Texas city. Diagn Microbiol Infect Dis 2010; 66:445-8.
14. Yigit, H., G. J. Anderson, J. W. Biddle, C. D. Steward, J. K. Rasheed, L. L. Valera, J. E. McGowan, Jr., and F. C. Tenover. Carbapenem resistance in a clinical isolate of Enterobacter aerogenes is associated with decreased expression of OmpF and OmpC porin analogs. Antimicrob Agents Chemother 2002; 46:3817-22.
15. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing; Twenty-first Informational Supplement. CLSI document M100-S21. Wayne, PA: CLSI. 2010.
16. Lee, K., Y. S. Lim, D. Yong, J. H. Yum, and Y. Chong. Evaluation of the Hodge test and the imipenem-EDTA doubledisk synergy test for differentiating metallo-beta-lactamaseproducing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 2003; 41:4623-4629.
17. Lee, H. K., Y. J. Park, J. Y. Kim, E. Chang, S. G. Cho, H. S. Chae, and C. S. Kang. Prevalence of decreased susceptibility to carbapenems among Serratia marcescens, Enterobacter cloacae, and Citrobacter freundii and investigation of carbapenemases. Diagn Microbiol Infect Dis 2005; 52:331-6.
18. Song, W., H. Lee, K. Lee, S. H. Jeong, I. K. Bae, J. S. Kim, and H. S. Kwak. CTX-M-14 and CTX-M-15 enzymes are the dominant type of extended-spectrum beta-lactamase in clinical isolates of Escherichia coli from Korea. J Med Microbiol 2009; 58:261-6.
19. Lee, K., D. Yong, Y. S. Choi, J. H. Yum, J. M. Kim, N. Woodford, D. M. Livermore, and Y. Chong. Reduced imipenem susceptibility in Klebsiella pneumoniae clinical isolates with plasmid-mediated CMY-2 and DHA-1 beta-lactamases co-mediated by porin loss. Int J Antimicrob Agents 2007; 29:201-6.
20. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. Interpreting chromosomal DNA restriction patterns produced by pulsedfield gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33:2233-9.
21. Domenech-Sanchez, A., S. Hernandez-Alles, L. Martinez-Martinez, V. J. Benedi, and S. Alberti. Identification and characterization of a new porin gene of Klebsiella pneumoniae: its role in beta-lactam antibiotic resistance. J Bacteriol 1999; 181:2726-32.